Is Apixaban Available Now? A Comprehensive Review of Its Availability and Uses
Apixaban, a factor Xa inhibitor, has been a significant player in the anticoagulant market since its approval by the U.S. Food and Drug Administration (FDA) in 2012. It is primarily used to prevent stroke in patients with non-valvular atrial fibrillation, treat deep vein thrombosis (DVT), and pulmonary embolism (PE). The medication has gained widespread acceptance … Read more